This Essay explores how menopausal bodies are managed and monitored through both menopausal hormone therapy (MHT) and the burgeoning market for technology-driven menopause products and services. While each of these allegedly improves the menopause experience, a closer investigation reveals a more complex interaction of profit motives and traditional notions of gender identity. The Essay identifies problems with—and suggests some solutions for reforming—current practices of monitoring and managing the menopausal body.
Careful consideration of menopause brings this Essay into ongoing conversations about theorizing beyond the gender binary and stereotypical notions of femininity. Purveyors of both MHT and menopause-related digital products and services appeal to mostly cisgender women by emphasizing ideas of youthfulness, attractiveness, and sexual desirability. We locate these profit seekers within “menopause capitalism,” the marketing and selling of menopause-related products through messages that celebrate autonomy, community, or femininity from entities that are, at their core, commercial enterprises.
Naomi Cahn, Bridget J. Crawford & Emily Gold Waldman, Managing and Monitoring the Menopausal Body, 2022 U. Chi. Legal F. 41, https://digitalcommons.pace.edu/lawfaculty/1238/.